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Background: Hospital-acquired pneumonia (HAP) due to Achromobacter has become
a substantial concern in recent years. However, HAP due to Achromobacter in the
elderly is rare.
Methods: A retrospective analysis was performed on 15 elderly patients with HAP due
to Achromobacter spp., in which the sequence types (STs), integrons, biofilm production
and antibiotic resistance of the Achromobacter spp. were examined.
Results: The mean age of the 15 elderly patients was 88.8 ± 5.4 years. All patients had
at least three underlying diseases and catheters. Clinical outcomes improved in 10 of the
15 patients after antibiotic and/or mechanical ventilation treatment, but three patients
had chronic infections lasting more than 1 year. The mortality rate was 33.3% (5/15).
All strains were resistant to aminoglycosides, aztreonam, nitrofurantoin, and third- and
fourth-generation cephalosporins (except ceftazidime and cefoperazone). Six new STs
were detected. The most frequent ST was ST306. ST5 was identified in two separate
buildings of the hospital. ST313 showed higher MIC in cephalosporins, quinolones and
carbapenems, which should be more closely considered in clinical practice. All strains
produced biofilm and had integron I and blaOXA-114-like. The main type was blaOXA-114q.
The variable region of integron I was different among strains, and the resistance gene
of the aminoglycosides was most commonly inserted in integron I. Additionally, blaPSE-1
was first reported in this isolate.
Conclusion: Achromobacter spp. infection often occurs in severely ill elders
with underlying diseases. The variable region of integrons differs, suggesting that
Achromobacter spp. is a reservoir of various resistance genes.
Keywords: hospital-acquired pneumonia, Achromobacter, biofilm, elderly, integron
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INTRODUCTION
Achromobacter is a ubiquitous, non-fermenting, gram-negative
bacterium that lives in soil and aquatic environments. In recent
years, many studies have shown that this opportunistic pathogen
can lead to various infections, such as sepsis, bacteremia,
urinary infection, endocarditis, and peritonitis, especially in
immunocompromised individuals (Aisenberg et al., 2004).
Moreover, this organism can colonize various medical devices,
such as disinfectant-soaked unwoven cleaning cloth (Oie et al.,
2012), intravascular pressure transducer (Gahrn-Hansen et al.,
1988), and chlorhexidine (Vu-Thien et al., 1998).
To distinguish different Achromobacter strains, various
methods have been applied. Similar to OXA-50-like enzymes
from P. aeruginosa or OXA-51/69 from A. baumannii, the
blaOXA-114-like gene is a known characteristic of Achromobacter
(Doi et al., 2008; Turton et al., 2011). Additionally, multilocus
sequence typing (MLST) is one of the best methods for use in
epidemiological studies in the world. There are more than 300
STs in the MLST database distributed across the world. However,
due to the low incidence of Achromobacter infections, no clone
complex has been reported.
Elderly patients often have underlying diseases and frequently
suffer from chronic infections, which may result in continuous
exposure to various types of antibiotics. This exposure may
contribute to antibiotic resistance. Based on previous studies,
integrons and the inborn RND-Type Multidrug Eﬄux Pump
(Bador et al., 2011) are the main reasons for antibiotic resistance.
Various integrons (intI/intII) have been detected (Traglia et al.,
2012). Additionally, extended-Spectrum β-Lactamases (ESBL)
and metallo-b-lactamase (MBL) production by Achromobacter
spp. has been detected in the last decade. In Europe, blaVEB
and blaTMB inserted in integrons were found in Achromobacter
spp. (Neuwirth et al., 2006; El Salabi et al., 2012). Various
subtypes of blaVIM have been detected in integron I in Asia and
Europe (Riccio et al., 2001; Shin et al., 2005; Sofianou et al.,
2005). Infections, pandemic or sporadic, are often related to the
location of resistance genes (chromosome/plasmid). Thus, the
insertion of a new blaIMP-type gene in plasmids inA. xylosoxidans
has attracted wide attention because it may spread easily
(Yamamoto et al., 2012). Moreover, the inherent blaOXA-114-like
genes may result in a higher level of OXA-114-mediated-lactam
resistance because of the insertion sequence elements (Doi et al.,
2008). Therefore, Achromobacter spp. is an emerging pathogen
and is becoming a reservoir for horizontal genetic transfer
elements involved in spreading antibiotic resistance (Traglia
et al., 2012).
Hospital-acquired pneumonia (HAP) due to Achromobacter
spp. has emerged as a substantial concern in recent years.
Pulmonary involvement has been frequently reported in cases
with underlying disease, especially in cystic fibrosis (CF) (Dunne
and Maisch, 1995; Ferroni et al., 2002). In CF patients,
A. xylosoxidans isolated from sputum increased gradually (Zemel
et al., 2000; Liu et al., 2002). However, CF is a rare disease
in China. In non-CF patients, several cases of pneumonia
have been reported in patients with underlying malignancy
(Aisenberg et al., 2004), those with IgM deficiency (Dworzack
et al., 1978) and those on mechanical ventilation (Chandrasekar
et al., 1986). Additionally, approximately half of these non-CF
patients originated from the community, which may be related
to the soil and aquatic environments (Swenson and Sadikot,
2015). However, HAP due to Achromobacter spp. in the elderly
is rare.
The features of this organism in the elderly need to be urgently
studied. Therefore, this study aimed to understand the clinical
characteristics, epidemiology, biofilm production and integrons
of Achromobacter spp. in elderly patients with HAP.
MATERIALS AND METHODS
Patients
Fifteen patients with HAP due to Achromobacter spp. treated
in a geriatric ward in China from September 2008 to May
2012 were enrolled in this study. The diagnostic criteria of
HAP were as described previously (Rotstein et al., 2007).
Patient demographics and clinical characteristics (underlying
disease, invasive manipulation, therapy, and mortality) were
collected. The Acute Physiology and Chronic Health Evaluation
II (APACHE II), Sequential Organ Failure Assessment (SOFA)
score and Clinical Pulmonary Infection Score (CPIS) were
evaluated within the first 24 h. Chronic infection was defined
as a positive sputum culture on at least three occasions over
a 6-month period, as previously suggested (Trancassini et al.,
2014).
Microbial Identification and blaOXA-114-like
Analysis
Achromobacter spp. was cultured from sputum or aspirations
more than twice and was the dominant species in the culture.
All the strains were identified by the API 20 NE system and
the Vitek II system as described previously (Otto-Karg et al.,
2009; Tena et al., 2014). Species identification was confirmed by
16S ribosomal RNA gene sequencing (Mellmann et al., 2003).
To further classify this organism, a specific PCR based on
the detection of blaOXA-114-like was performed (Turton et al.,
2011).
Multilocus Sequence Typing
The primers and reaction conditions of seven housekeeping
genes (nusA, rpoB, eno, gltB, lepA, nuoL, nrdA) were designed
by searching Pubmlst1. Allelic profiling and ST determination
were also performed through the above website. Additionally,
phylogenetic analysis of housekeeping genes and eBURST
analysis were performed. The concatenation of the seven
housekeeping genes (total of 2249 bp) of Achromobacter
spp. was performed. A dendrogram was constructed from
the concatenated sequences by the neighbor-joining method
(MEGA 6.05). The eBURST analysis was conducted using
eBURST V3.
1http://pubmlst.org/achromobacter/
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Biofilm Production Assay
All isolates were individually cultured overnight in M-H medium
(OXOID). A monoclonal sample from the M-H medium was
mixed with LB medium to prepare a bacterial suspension of
0.5 units. Bacterial suspensions (200 µl) were inoculated in
a 96-well plate followed by 48 h of incubation at 37◦C in a
bacterial incubator (German He Liman). Plankton bacteria were
removed by washing three times with distilled water every 30 s.
The wells were dyed at room temperature for 5 min and then
incubated with 200 µl of 1% Crystal Violet dye for 20 min.
They were then washed twice with distilled water and dried
at 37◦C for 30 min. Two hundred microliters of 95% ethanol
was added into each well, and the optical density (OD) at
570 nm was measured in a microtiter auto reader (Thermo Fisher
Scientific, US) (Trancassini et al., 2014; Zhang et al., 2016). ATCC
Escherichia coli DH5a (Ac) was used as a negative control. The
established criteria (four levels of biofilm-forming ability) were
the following: (1) N: no biofilm producer (−), A ≤ Ac; (2) W:
weakly positive (++), Ac < A ≤ 2Ac; (3) M: moderately positive
(++), 2Ac < A ≤ 4Ac; and (4) S: strongly positive (+++),
A > 4Ac (Stepanovic´ et al., 2007).
Susceptibility Testing
Antimicrobial susceptibility testing was conducted using the
microbroth dilution method as described previously (Yamamoto
et al., 2012). The etest was employed for polymyxin B in M-H
medium (OXOID) (Table 1). The results were interpreted using
the 2015 Clinical and Laboratory Standards Institute (CLSI)
guidelines.
BlaOXA-114-like Analyses
The dendrogram analysis of blaOXA-114-like was performed
using MEGA (version 6.05). The alignment used for the tree
calculation and various amino acid sequences of OXA enzymes
FIGURE 1 | Schematic representation of the class 1 integron gene
cassettes in Achromobacter spp. isolates.
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were performed with Clustal X (version 1.83). To determine
whether different subtypes of blaOXA-114 relate to different
antibacterial spectra, antibacterial spectra were compared among
these subtypes.
PCR
Total DNA was prepared and used as a template for PCR
reactions. PCR screening for integrase (intI1, intI2, and intI3)
genes was performed as described previously (Yamamoto
et al., 2012). The primers used in this study are shown in
Supplementary Table S1 (Woodford et al., 2006; Poirel et al., 2011;
El Salabi et al., 2012; Poirel et al., 2012).
The primers designed for various regions were Pf:
GCATCCAAGCAGCAAG and Pr: AAGCAGACTTGACCTGA.
PCR was performed using the Pyrobest DNA Polymerase
according to the manufacturer’s instructions (Takara). PCR
products were resolved on 1.0% agarose gels, stained with
ethidium bromide, and photographed with UV illumination.
The PCR products were then sequenced after purifying
the DNA by using the Gel Extraction Kit according to the
manufacturer’s directions (Axygen). The products were
sequenced by Major Biological Medicine Technology Co Ltd in
Shanghai.
Nucleotide Sequence Accession
Numbers
The nucleotide sequences of the various regions in the integrons
reported in this study were submitted to the NCBI2 and assigned
the accession numbers KT454532, KT719385, KT719386, and
KT719387 (Figure 1).
RESULTS
Clinical Characteristics
These infections first occurred in 2008, and 2, 3, 5, 1,
and 3 infections happened per year from 2008 to 2012,
respectively. Patient characteristics are summarized in Table 2
2http://www.ncbi.nlm.nih.gov/
FIGURE 2 | Amino acid sequence differences in the OXA enzymes described in this study.
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and Supplementary Table S2. In total, 14 males and 1 female were
included in this study. The mean age was 88.8± 5.4 years. All the
patients had more than 3 diseases, and 10 of them had 3 or more
catheters. The primary underlying diseases were coronary heart
disease (CHD) and chronic pulmonary disease. Eleven patients
received proton pump inhibitors (PPI), three patients received
corticosteroids and two received chemotherapy. Almost all these
patients were treated with various antimicrobial therapies within
the previous 14 days. Chest imaging of all patients showed
patchy exudation. Pleural effusion was found in 33.3% (5/15) of
cases, and one case showed consolidation. The mean APACHE
II, SOFA and CPIS scores were 23.4 ± 7.7, 7.4 ± 2.7, and
7.6 ± 1.64, respectively. Twelve patients were given a different
antibiotic regimen after the antimicrobial susceptibility test. Nine
patients were treated by mechanical ventilation. Three patients
had chronic infections lasting more than 1 year. Of those with
infections, 10 were alive, and 5 (33.3%) died 30 days after
infection. The fatal cases were more likely to have sepsis (n= 3).
Diversity of blaOXA-114-like
All Achromobacter spp. strains had positive results for the
amplification of blaOXA-114-like (Figure 2). To further study
FIGURE 5 | Neighbor-joining dendrogram of concatenated sequences
of seven housekeeping genes from the MLST database.
the sequence diversity of blaOXA-114-like in Achromobacter spp.,
amino acid sequence comparison of the blaOXA-114-like gene was
conducted and an evolutionary tree were constructed (Figure 3).
The most frequent type was blaOXA-114q, which accounted for
53.3% (8/15) of isolates. Other genes included blaOXA-114r (three
cases), blaOXA-114h (three cases) and blaOXA-114t (one case). There
were amino acid differences among all of the isolates.
FIGURE 3 | Dendrogram analysis of OXA enzymes in Achromobacter spp. isolates. The tree was inferred for various blaOXA-114 types, blaOXA-243, and
blaOXA-253 using the neighbor-joining method.
Frontiers in Microbiology | www.frontiersin.org 6 May 2016 | Volume 7 | Article 621
fmicb-07-00621 May 5, 2016 Time: 16:44 # 7
Liu et al. Hospital Acquired Pneumonia Due to Achromobacter spp.
FIGURE 4 | The distribution of the 15 patients by admission department and year. : ST311 :ST307 :ST312 :ST5 :ST314 :ST313 ?:ST313
:ST306. CCU, cardiac intensive care unit; RICU, respiratory intensive care unit. General Medicine (the blue underline) is in another building. The same sequence
type is shown in the same color square. The square represents male gender. The star represents female gender.
MLST and BF
Based on MLST, four cases belonged to ST5, and these cases
were distributed in two separate buildings of the hospital.
Six new STs were detected (ST306, 307, 311, 312, 313, 314).
Five cases belonged to ST306, and 2 belonged to ST313
(Figure 4). Phylogenetic analysis of housekeeping genes showed
that there was a less obvious relationship between ST5 and ST314
(Figure 5), which were found in cases from the general medicine
department in a different building from where the other STs
were isolated. Additionally, all STs available in the database were
analyzed via eBURST. The results show that ST313 belongs to the
ST1 CC (clone complex), and HAP caused by this organism may
occur sporadically (Figure 6).
All strains were able to produce a biofilm on 96-well plates
(Table 1). Nearly half of the strains were moderate biofilm
producers, four strains were strong producers, and five strains
were weak producers.
Antibiotic Resistance and Integron
Variable Region
All strains were resistant to aminoglycosides, aztreonam,
nitrofurantoin, and third- and fourth-generation cephalosporins
(except ceftazidime and cefoperazone). Approximately half of
these strains were resistant to ciprofloxacin, tetracycline and
imipenem, but the sensitivity to piperacillin/tazobactam and
meropenem was close to 70%.
All the blaOXA-114-like type strains showed high resistance
to cefepime, cefotaxime and ceftriaxone and high sensitivity
to piperacillin and piperacillin/tazobactam. It is interesting
that both blaOXA-114t and blaOXA-114r strains are resistant to
ciprofloxacin and show higher resistance to carbapenems than
other subtypes (Table 3, Figure 7). However, due to the small
sample, a large sample analysis should be conducted to further
examine this finding.
We examined three types of integrons (intI, intII, intIII), and
all the strains had intI, but neither intII nor intIII were found.
In the variable region in intI, aadB + aadA2 were detected in
10 strains, aadB was inserted in two strains, dfrA17+ aacA4
in one isolate, and blaPSE-1+aac(6′)-II + aadB in one isolate
(Supplementary Figure S1).
DISCUSSION
Achromobacter spp. have been frequently detected by the cystic
pulmonary fibrosis (CF) center in recent years (Lambiase et al.,
2011; Pereira et al., 2011; Amoureux et al., 2013b; Llorca
Otero et al., 2016). A study showed that colonization mostly
occurred in elderly patients who had more pronounced lung
damage and poorer lung function (De Baets et al., 2007).
Chronic pulmonary disease and respiratory tract infections
often occur in elderly patients. In our study, elderly patients
had more than three diseases, particularly CHD, chronic
pulmonary disease and cerebrovascular disease. Additionally,
10 had 3 or more indwelling catheters. These catheters
may contribute to the higher APACHE II and SOFA scores.
The mortality rate was 33.3% (5/15), which is higher than
that in other studies (Gómez-Cerezo et al., 2003; Aisenberg
et al., 2004). Piperacillin/tazobactam and meropenem showed
a strong ability to treat the infection, consistent with the
in vitro susceptibility tests. In our study, nine patients (60%)
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FIGURE 6 | eBRUST analysis of all STs of Achromobacter. Circles represent different STs; blue represents a primary founder, yellow represents a subgroup
founder, red denotes STs found in the present study dataset only.
TABLE 3 | The antibacterial spectrum of blaOXA-114-like strain.
Total CAZ FEP CTX CRO CPZ LEV CIP IPM MEM PIP TZP
Number NR R NR R NR R NR R NR R NR R NR R NR R NR R NR R NR R
blaOXA-114q 8 6 2 0 8 0 8 0 8 6 2 5 3 2 6 4 4 7 1 7 1 7 1
blaOXA-114h 3 2 1 0 3 0 3 0 3 2 1 2 1 2 1 3 0 3 0 2 1 2 1
blaOXA-114r 3 2 1 0 3 0 3 0 3 2 1 2 1 0 3 1 2 1 2 3 0 3 0
blaOXA-114t 1 1 0 0 1 0 1 0 1 1 0 1 0 0 1 0 1 0 1 1 0 1 0
FIGURE 7 | The antibacterial spectrum of blaOXA-114-like -containing strains. 1: blaOXA-114q, 2: blaOXA-114q, 3: blaOXA-114q, 4: blaOXA-114q; CAZ, ceftazidime;
FEP, cefepime; CTX, cefotaxime; CRO, ceftriaxone; CPZ, cefoperazone; LEV, levofloxacin; CIP, ciprofloxacin; IPM, imipenem; MEM, meropenem; PIP, piperacillin;
TZP, piperacillin/tazobactam.
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received mechanical ventilation. This organism can colonize
humidifiers, which is an issue that needs to be addressed
when a patient receives mechanical ventilation (Tena et al.,
2005).
More than 300 types of Achromobacter spp. have been
recorded in the MLST database. ST5 was first cultured from a
CF patient in USA. In our hospital, four cases were infected by
this type from 2009 to 2012 in two buildings. These patients
did not appear to be clustered in space or time. Moreover,
the MIC of carbapenems for ST5 was lower. From 2008
to 2010, ST306 was detected in the Respiration and CCU.
Interestingly, the same ST showed various antibiotic-resistance
spectra, indicating different resistance mechanisms. The other
STs (ST307, ST311, ST312, ST313, and ST314) did not appear
to be clustered in space or time. Additionally, the location and
timing were not consistent with the six non-clustered cases.
However, no strain was detected from doctors’ hands or from
medical equipment. The source of their infection could not
be determined. Two strains (ST313) showed higher MIC for
cephalosporins, quinolones and carbapenems, which should be
considered in clinical practice.
It has been proposed that blaOXA-114-like is an inherent gene for
Achromobacter xylosoxidans (Turton et al., 2011). Additionally,
the diversity of blaOXA-114-like has been reported (Amoureux et al.,
2013a). BlaOXA-114q, blaOXA-114r , blaOXA-114h and blaOXA-114t were
also detected in our study, which confirmed the diversity of this
gene. We have listed the similarities and differences in amino
acids among these genes in our isolates. Further studies are
needed to understand the function of these differences.
In our study, the strains isolated from patients who were
supported by mechanical ventilation had stronger biofilm
production. Additionally, the strong biofilm producers (No.
8, 10, 11) showed higher MIC of carbapenems. These
characteristics may be shared by other Gram-negative biofilm
producers.
Various regions of integrons can carry various resistance
genes. In Argentina, class 1 integrons and class 2 integrons
were detected in an Achromobacter spp., including various
antibiotic-resistant genes (Traglia et al., 2012). In the present
study, only class 1 integrons were detected, and all strains
were resistant to aminoglycosides, consistent with the three
types of genes (aadB, aadA2 and aacA4) detected in the
integron.
The overuse of antibiotics may be a reason for the increasing
opportunistic infections with resistant microorganisms (Tan
et al., 2002). In vitro, these isolates showed high sensitivity
to trimethoprim/sulfamethoxazole, polymyxin B, meropenem
and piperacillin/tazobactam. In clinical practice, due to the
hepatic and renal toxicity of trimethoprim/sulfamethoxazole
and polymyxin B, meropenem and piperacillin/tazobactam are
frequently used in therapy. Additionally, in our study, nine
patients survived after meropenem and piperacillin/tazobactam
therapy. However, four isolates showed high resistance
to imipenem in vitro. In a previous study, the blaVIM
located in integron I was reported in both Asia and Europe
(Riccio et al., 2001; Shin et al., 2005; Sofianou et al., 2005).
Additionally, a new type of blaIMP inserted in plasmids
was detected in A. xylosoxidans, which could easily trigger
a pandemic of carbapenem-resistant isolates (Yamamoto
et al., 2012). Unfortunately, metallo-b-lactamase (MBL)
gene cassettes involved in carbapenem resistance were not
detected in the integrons. Other mechanisms may account
for the carbapenem resistance observed in this study.
Thus, whole genome sequencing may be needed for further
study.
Many studies showed that dfrA was frequently detected in
integrons (Yu et al., 2003, 2004). In our study, dfrA17 was
found in integron I, which was once detected in patients
with urinary tract infection from another Gram-negative
organism in Korea. However, the clinical specimens of our
patients were sputum samples. The spread of dfrA17 may
be related to the plasmid (Yu et al., 2003). The blaPSE-1
gene was first reported in Achromobacter spp. This gene
can induce carbenicillin-hydrolyzing beta-lactamases aimed
at carboxypenicillins, ureidopenicillins and cefsulodin. These
enzymes belong to molecular class A and functional group
2c (Bush et al., 1995), which can be frequently detected
in Gram-negative organisms. These results indicate that this
organism may be a reservoir of horizontal genetic transfer
elements for spreading antibiotic resistance (Collis and Hall,
1995).
This study has several limitations. First, it is a small
retrospective study conducted over 5 years. Therefore, the
source of infection could not be determined, and our results
cannot be generalized to other populations. Second, these cases
of Achromobacter spp. in China are not routinely reported.
Third, the mechanism of resistance to carbapenems was
unclear. Whole genome sequencing may be needed in further
studies.
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